Abiopharma

News list

📋 Wilson Mark Andrew (Ex-Officer) plans to sell 79K shares of NEKTAR THERAPEUTICS (at $72.64 each, total $5.7M) Filed: Mar 13, 2026 | ID: 002286

Full text

News bot March 13, 2026, 5:05 p.m.
📋 Form 144 Filing: Wilson Mark Andrew

Company: NEKTAR THERAPEUTICS

Filing Date: 2026-03-13

Relationship: Former Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 78,510
- Price per Share: $72.64
- Total Value: $5,702,966.40
- Planned Sale Date: 2026-03-13
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-24006
- Issuer Contact Phone: 4154825300
- Issuer Address: 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 28687963.0
- Number of Securities to be Sold: 3
- Signature: /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mark Wilson